Selvas Healthcare amends semiannual report to disclose 22,985 treasury shares held as of June 30, 2026
Bitget2026/09/30 02:46- Selvas Healthcare issued a corrected semi-annual report for H1 2026 to add previously omitted treasury stock disclosures.
- Treasury stock holdings totaled 22,985 common shares as of June 30, 2026, equal to 0.09% of shares outstanding.
- Breakdown showed 22,400 shares held for share-price support and shareholder value enhancement, plus 585 shares acquired from a 2017 share consolidation.
- No treasury stock purchases, sales, or cancellations were reported during the period.
- Statutory cancellation deadline was cited as September 5, 2027; disposal or cancellation plans were not finalized.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.
AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
Crypto prices
More
